You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The registry from the American Society for Clinical Pathology aims to eventually collect metrics on how lab services impact patient outcomes.
As gene drive research is being proposed to find a solution to infectious disease outbreaks, some organizations say we must lay an ethical groundwork for its use.
NIH officials have reopened public comments through Dec. 12 on a plan to ease access to certain categories of genomic summary results.
Attendees at the recent AMP meeting grappled with issues brought to light in a lawsuit regarding the alleged negligent misclassification of a patient's genetic variant.
A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.
The wide-ranging discussion with witnesses from Stanford, Johns Hopkins, and Editas Medicine touched on recent advances in research and questions of safety.
According to survey results presented at ASHG, most genetics experts support somatic and germline gene editing, though few favor trait enhancement.
With only one test FDA-approved for primary hrHPV screening, groups express concern about feasibility of moving away from co-testing
Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.
The biggest losers following the release of the preliminary PAMA rates may be Quest and LabCorp, analysts said today.
Genetic counselors and patient advocates say more people are refusing genetic testing because they're uncertain of how it will impact their insurance.
The PHG Foundation's report calls for raising clinician awareness about ctDNA testing technology in order to improve patient access to targeted therapies.
The NIH is soliciting public comments on a planned update to its Genomic Data Sharing Policy that guides data management of genomic summary results.
The group is proposing women ages 30 to 65 be screened with cervical cytology every three years or receive testing for high-risk HPV every five years.
The bill, which was approved by a Senate subcommittee yesterday, would increase the National Institutes of Health's fiscal 2018 budget to $36.1 billion.
The bill would increase the NIH's fiscal 2018 budget to $36.1 billion — $2 billion more than the agency was allocated in the prior fiscal year.
The law broadens the ability of law enforcement agencies to use rapid DNA sequencing technology and upload resulting data into a federal database.
Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
The increase includes greater spending on Alzheimer's disease research, precision medicine, and cancer research initiatives.
The Bidens have convened a diverse board and staff with the goal of continuing efforts to accelerate research and development begun under the Cancer Moonshot Initiative.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.